1 / 15

STRATEGY FOR COMBATTING THE RISE OF DRUG-RESISTANT BACTERIA IN THE US

STRATEGY FOR COMBATTING THE RISE OF DRUG-RESISTANT BACTERIA IN THE US. David Marash-Whitman 11/20/13. KPC ( Klebsiella pneumoniae carbapenemase ) 18 infected patients 6 fatalities complete drug resistance persistent presence at NIH center. THE PROBLEM. increased usage leads

felix-combs
Download Presentation

STRATEGY FOR COMBATTING THE RISE OF DRUG-RESISTANT BACTERIA IN THE US

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. STRATEGY FOR COMBATTING THE RISE OF DRUG-RESISTANT BACTERIA IN THE US David Marash-Whitman 11/20/13

  2. KPC (Klebsiellapneumoniae carbapenemase) 18 infected patients 6 fatalities complete drug resistance persistent presence at NIH center

  3. THE PROBLEM increased usage leads to decreased future effectiveness antibiotics are being used excessively development of new antibiotics is expensive finite source of future antibiotics

  4. THE SOLUTION promote conservative use of antibiotics incentive to comply remove barriers to compliance

  5. THE SOLUTION bioethical responsibility timeliness affordability

  6. THE SOLUTION bioethical responsibility timeliness affordability

  7. THE SOLUTION bioethical responsibility timeliness affordability

  8. THE SOLUTION promote conservative use of antibiotics increase incentive to comply remove barriers to compliance

  9. THE SOLUTION Prove-It Sepsis Septifast Sepsitest $50 $75 $125 6 hours 3.5 hours <1 hour 25 species 70 species 345 species

  10. THE SOLUTION bioethical responsibility timeliness affordability

  11. THE SOLUTION bioethical responsibility timeliness affordability

  12. OUTCOMES accessibility of medical technology reduction of inappropriate antibiotic prescriptions

  13. SHORT TERM PREVENTION LONG TERM general health development of new antibiotics development of new antimicrobial therapies vaccination conservative use of antibiotics (in humans) (in animals)

More Related